Prognostic implications of cell kinetics, histopathology and pathologic stage in non‐Hodgkin's lymphomas
- 1 November 1989
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 7 (6) , 411-422
- https://doi.org/10.1002/hon.2900070604
Abstract
Cell kinetics ([3H]‐thymidine labelling index, [3H]‐Thy LI) were determined on pathologic lymph nodes from 175 untreated adult patients. [3H]‐Thy LI significantly differed in low‐grade and high‐grade malignancy groups according to the Kiel classification (median values, 1.8 per cent and 10.4 per cent, respectively) and in low, intermediate, high grade according to the Working Formulation (median values: 1.7 per cent, 4.8 per cent and 14.2 per cent, respectively) but was unrelated to pathologic stage or patient's age. Cell kinetics, histo‐pathology, pathologic stage and patient's age were significant discriminants of 6‐year survival. Multivariate analysis was performed by Cox's proportional hazard model to investigate the role of [3H]‐Thy LI after making allowance for the other prognostic factors. When [3H]‐Thy LI was added to the model, a large increase (chi square = 29.94) contributed by the cell kinetic variable in identifying patients at different risk was revealed.Keywords
This publication has 32 references indexed in Scilit:
- Cell kinetics as a prognostic tool in patients with metastatic malignant melanoma of the skinCancer, 1987
- European School of Oncology: Management of non-Hodgkin's lymphomas: Conclusions of the European School of Oncology meeting, 1986European Journal of Cancer and Clinical Oncology, 1987
- PROGNOSTIC RELEVANCE OF TUMOUR-CELL GROWTH FRACTION IN MALIGNANT NON-HODGKIN'S LYMPHOMASThe Lancet, 1987
- Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosisBritish Journal of Cancer, 1987
- Cell proliferation and DNA content in non-hodgkin' s lymphoma: Flow cytometry in relation to lymphoma classificationCancer, 1986
- Reproducibility and prognostic value of different non-Hodgkin's lymphoma classifications: Study based on the clinicopathologic relations found in the EORTC trial (20751)European Journal of Cancer and Clinical Oncology, 1985
- Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determinedin situwith the monoclonal antibody Ki‐67Hematological Oncology, 1984
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Uptake of thymidine in lymphoma cells obtained through fine-needle aspiration biopsy. Relation to prognosis in non-hodgkin's lymphomasEuropean Journal of Cancer and Clinical Oncology, 1981
- Percentage of cells in the S phase of the cell cycle in human lymphoma determined by flow cytometry. Correlation with labeling index and patient survivalCytometry, 1980